29 Apr [MCE] Antibody Drug Conjugate —“Biological Missile” of Targeted Cancer Therapy
Antibody drug conjugates (ADCs) are class of targeted therapies that combine precise targeting capabilities of monoclonal antibodies with the potent effects of cytotoxic payloads. Known for their ability to selectively identify and destroy cancer cells, ADCs represent a groundbreaking advancement in oncology. Figure 1. The...